Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting
Taraz Samandari(Research Network (United States)), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cynthia Lee(Program for Appropriate Technology in Health), Jack Hutter, Nonhlanhla N. Mkhize(Respiratory and Meningeal Pathogens Research Unit), Walter Otieno, Grace Mboya(Kenya Medical Research Institute), John J. Aponte(Manhiça Health Research Centre), Christian F. Ockenhouse(U.S. President's Malaria Initiative), Haajira Kaldine(National Health Laboratory Service), Margaret Yacovone(National Institutes of Health), Sufia Dadabhai, Jia Jin Kee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Penny L. Moore(National Health Laboratory Service), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Laura Polakowski(University of Maryland, Baltimore), Sinethemba Bhebhe(National Center for Communicable Diseases), Asa Tapley(University of Washington), Millicent Achola(United States Army Medical Research Directorate - Africa), Nigel Garrett(Centre for the AIDS Programme of Research in South Africa)
Cited by 0
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557